Mesenchymal Stem Cell-Derived Exosomes in 3D-Bioprinted Hydrogel Scaffolds for Cartilage Regeneration: Advances, Mechanisms, and Translational Challenges

Abstract

Despite the current advances in the field, articular cartilage defects and osteoarthritis remain a challenge in the clinic due to the fact that mature cartilage lacks blood supply, is poorly cellular and has a weak intrinsic repair response. Although conventional treatments focusing on the symptoms can alleviate pain and surgical methods can restore some function in a few lesions, regeneration of hyaline cartilage with native zonal architecture is rare. Exosomes, or small extracellular vesicle enriched products, derived from mesenchymal stem/stromal cells have been the focus of much interest as cell-free regenerative signals due to their ability to contain regulatory microRNAs, proteins, lipids and other biomolecules that can affect chondrocytes survival, extracellular matrix production, macrophage phenotype and inflammatory signalling. Freely injected EVs, however, are diluted, their location is unpredictable, there is no consistency in dosage and very little control over the release of EVs at the injection site. Three dimensional bioprinted hydrogel scaffolds provide a complementary biotechnology approach, where the defect-matched architecture, matrix-like support, mechanical protection and controlled spatial distribution of bioactive cargo are provided. This is a very important research paper that assesses the progress, mechanisms and translational hurdles of using MSC-derived exosomes for the development of 3D-bioprinted hydrogel scaffolds for cartilage regeneration. The analysis suggests that the most scientifically justifiable approach is an integrated exosome-bioink platform in which the design of vesicles, their identity and potency, the mechanics of the hydrogel, the release kinetics of the vesicles, the printability of the bioink, the sterility and regulatory grade manufacturing are all designed together. Preclinical evidence is in favor of chondroprotective, anti-inflammatory and pro-regenerative activity, but human evidence is preliminary and is not sufficient for the routine clinical use. However, before translation, standardised reporting of extracellular vesicles, reproducible potency assays, clinically relevant cartilage models, long-term studies in animals and GMP-compatible manufacturing and meticulously controlled clinical trials will be required.

Keywords: Mesenchymal Stem Cells; Exosomes; Extracellular Vesicles; 3D Bioprinting; Hydrogel Scaffold; Cartilage Regeneration; Osteoarthritis; Tissue Engineering and Regenerative Medicine

Citation

Adeel Asghar. Mesenchymal Stem Cell Derived Exosomes in 3D-Bioprinted Hydrogel Scaffolds for Cartilage Regeneration: Advances, Mechanisms, and Translational Challenges. WebLog J Stem Cell Res Ther. wjscrt.2026. i1206. https://doi.org/10.5281/zenodo.22842182